Clinical Trial Update: Pharmacokinetic Behavior of Phenolic Acids Derived From Black Tea [NA]

View source ↗

Summary

A completed clinical trial update examining the pharmacokinetic behavior of phenolic acids derived from black tea in the context of cardiovascular diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Phenolic acids derived from black tea

Snippet

Sponsor: Unilever R&D | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED